SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029605
Filing Date
2023-08-21
Accepted
2023-08-21 16:05:46
Documents
34
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 390035
2 ex31-1.htm EX-31.1 18375
3 ex32-1.htm EX-32.1 7420
  Complete submission text file 0001493152-23-029605.txt   1772737

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE glsi-20230630.xsd EX-101.SCH 12714
5 XBRL CALCULATION FILE glsi-20230630_cal.xml EX-101.CAL 19704
6 XBRL DEFINITION FILE glsi-20230630_def.xml EX-101.DEF 50349
7 XBRL LABEL FILE glsi-20230630_lab.xml EX-101.LAB 126513
8 XBRL PRESENTATION FILE glsi-20230630_pre.xml EX-101.PRE 101110
28 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 135442
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 231189168
SIC: 2834 Pharmaceutical Preparations